Navigation Links
Improved Pharma to teach at upcoming Sustainable Medicines in Africa Program
Date:8/29/2019

Prof. Stephen R. Byrn travels to Africa several times a year to teach in the Sustainable Medicines in Africa program, which includes a master’s degree in biotechnology innovation and regulatory science. The next course will take place in Arusha, Tanzania September 2nd through 13th, 2019. Topics to be addressed include Manufacturing, Quality, Regulation, Devices, Harmonization, Innovation, Drug Development, Legal, Control, Lab, Statistics, Audits, Inspections, and INDs.

About 12 years ago, shortly after selling SSCI, Byrn was contacted by Sister Zita Ekeocha of the Medical Missionaries of Mary in Africa. She was teaching industrial pharmacy at the Kilimanjaro School of Pharmacy (KSP) in Moshi, Tanzania, and she was looking for a way to expand the program for her students. Byrn and his wife Sally decided to take some of the funds from the sale of SSCI and used it to help establish the program, working with Purdue University and the KSP. The goal of the program is to enable the manufacture of quality medicines in Africa by Africans. Since its inception, the program has graduated over 100 students and has now expanded to the MS-TCDC, ActionAid Denmark in Arusha, Tanzania, with the support of a grant from the Bill and Melinda Gates Foundation. Some of the profits from Improved Pharma are also used to help support the program in Africa.

For more information on our work in Africa, please visit this link.

Stephen R. Byrn, Ph.D., FAAPS, is the Charles B. Jordan Professor of Medicinal Chemistry for the Department of Industrial and Physical Pharmacy and co-director of the Biotechnology Innovation and Regulatory Science Center at Purdue University. He is also the founder of two pharmaceutical research and information companies, SSCI West Lafayette and Improved Pharma LLC. He currently serves as the Chief Scientific Officer for Improved Pharma, a research and information company dedicated to improving pharmaceutical methods, formulations, and processes. Current research is focused on using synchrotron X-ray powder diffraction to understand the structure of amorphous materials.    

About Improved Pharma
For more information about the techniques discussed in this article or about Improved Pharma’s services, please contact us at 1-765-463-9951 or info@improvedpharma.com.

Read the full story at https://www.prweb.com/releases/improved_pharma_to_teach_at_upcoming_sustainable_medicines_in_africa_program/prweb16530427.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. KBioBox Offers Improved GUIDE-Seq Analysis Pipeline for CRISPR Experiments.
2. Cambridge Semantics to Present Smart Data Lakes Findings for Improved Pharma R&D at Bio-IT World Conference and Expo 2017
3. Thermo Fisher Scientific Demonstrates Improved differentiation of Stem Cell-derived Neurons and Downstream Applications
4. Mitotech’s SkQ1 Improved Visual Acuity in Leber’s Hereditary Optic Neuropathy (LHON) Patients
5. Keystone Nano Announces Start Of Clinical Testing Of Ceramide NanoLiposome For The Improved Treatment Of Cancer
6. Technology and Telemedicine Advancements in Healthcare Boosting Improved Patient Care
7. Study Suggests Improved Method For Pinpointing If Prostate Cancer Will Return - Dr. David Samadi Investigates
8. Interbody-Fusion Outcomes May Be Improved by Use of Invibio's PEEK-OPTIMA™ HA Enhanced Polymer
9. Quadrant Plastics and MediTECH Present Material Technologies Key to Improved Performance and Reduced Production Costs in Medical Device Market at OMTEC 2016
10. New Research Reviews Tests for Improved Mesothelioma Diagnosis, According to Surviving Mesothelioma
11. Shimadzu Introduces New ATHAP Matrix Kits for Improved Characterization of Hydrophobic Peptides and Proteins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
(Date:7/18/2020)... , ... July 17, 2020 , ... ... consulting firm for the life sciences and food industries, is pleased to announce ... of Clinical Research – Business Development. , Charles is an accomplished and results-driven ...
(Date:7/10/2020)... ... 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology company ... Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson will join ... Dr. Nissenson serves as an Emeritus Professor of Medicine at the David ...
(Date:7/1/2020)... (PRWEB) , ... June 29, 2020 , ... ... access to competitively procured purchasing contracts to its membership, recently named BioFit ... TIPS members with the opportunity to purchase ergonomic seating, cafeteria tables, book trucks ...
Breaking Biology Technology:
(Date:7/22/2020)... BARBARA, Calif. (PRWEB) , ... July 21, 2020 ... ... firm driving digital transformation and innovation in technology and compliance, announces a new ... medical device companies must ensure every layer of their technology stack complies with ...
(Date:7/4/2020)... ... 03, 2020 , ... Aesthetics Biomedical (ABM), a leading aesthetics ... not only the products and treatments developed, but also the dedicated team behind ... the brands built by ABM have received several honors already for 2020, each ...
(Date:6/28/2020)... ... June 25, 2020 , ... ... software solutions for biopharmaceutical R&D, today announced that it has entered into ... full-length multispecific antibodies (Multiclonics®), to support their translational and clinical research strategy ...
Breaking Biology News(10 mins):